224 related articles for article (PubMed ID: 29727238)
1. Treatment of osteoporosis: whom, how and for how long?
Dede AD; Callan M
Br J Hosp Med (Lond); 2018 May; 79(5):259-264. PubMed ID: 29727238
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic targets for osteoporosis.
Anagnostis P; Gkekas NK; Potoupnis M; Kenanidis E; Tsiridis E; Goulis DG
Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
[TBL] [Abstract][Full Text] [Related]
3. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
4. Abaloparatide and the Spine: A Narrative Review.
Thompson JC; Wanderman N; Anderson PA; Freedman BA
Clin Interv Aging; 2020; 15():1023-1033. PubMed ID: 32636617
[TBL] [Abstract][Full Text] [Related]
5. New Frontiers in Osteoporosis Therapy.
Cheng C; Wentworth K; Shoback DM
Annu Rev Med; 2020 Jan; 71():277-288. PubMed ID: 31509477
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis.
Compston JE; McClung MR; Leslie WD
Lancet; 2019 Jan; 393(10169):364-376. PubMed ID: 30696576
[TBL] [Abstract][Full Text] [Related]
7. Abaloparatide: Recombinant human PTHrP (1-34) anabolic therapy for osteoporosis.
Chew CK; Clarke BL
Maturitas; 2017 Mar; 97():53-60. PubMed ID: 28159062
[TBL] [Abstract][Full Text] [Related]
8. A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture.
O'Hanlon CE; Parthan A; Kruse M; Cartier S; Stollenwerk B; Jiang Y; Caloyeras JP; Crittenden DB; Barron R
Clin Ther; 2017 Jul; 39(7):1276-1290. PubMed ID: 28629610
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Therapy of Osteoporosis: What's New?
Iolascon G; Moretti A; Toro G; Gimigliano F; Liguori S; Paoletta M
Clin Interv Aging; 2020; 15():485-491. PubMed ID: 32273690
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis treatment: a missed opportunity.
Milat F; Ebeling PR
Med J Aust; 2016 Aug; 205(4):185-90. PubMed ID: 27510350
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment of osteoporosis.
Palacios S
Climacteric; 2022 Feb; 25(1):43-49. PubMed ID: 34382489
[TBL] [Abstract][Full Text] [Related]
12. Denosumab: mechanism of action and clinical outcomes.
Hanley DA; Adachi JD; Bell A; Brown V
Int J Clin Pract; 2012 Dec; 66(12):1139-46. PubMed ID: 22967310
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
Meier C; Uebelhart B; Aubry-Rozier B; Birkhäuser M; Bischoff-Ferrari HA; Frey D; Kressig RW; Lamy O; Lippuner K; Stute P; Suhm N; Ferrari S
Swiss Med Wkly; 2017; 147():w14484. PubMed ID: 28871570
[TBL] [Abstract][Full Text] [Related]
14. [To where and until when handle the osteoporosis?].
Uebelhart B; Ferrari S
Rev Med Suisse; 2017 Apr; 13(559):859-862. PubMed ID: 28727344
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for osteoporosis.
Feurer E; Chapurlat R
Expert Opin Emerg Drugs; 2014 Sep; 19(3):385-95. PubMed ID: 24995794
[TBL] [Abstract][Full Text] [Related]
16. Emerging anabolic agents in the treatment of osteoporosis.
Lovato C; Lewiecki EM
Expert Opin Emerg Drugs; 2017 Sep; 22(3):247-257. PubMed ID: 28756709
[TBL] [Abstract][Full Text] [Related]
17. An overview of the management of osteoporosis in the aging female population.
Amin U; McPartland A; O'Sullivan M; Silke C
Womens Health (Lond); 2023; 19():17455057231176655. PubMed ID: 37218715
[TBL] [Abstract][Full Text] [Related]
18. New anabolic therapies for osteoporosis.
Minisola S; Cipriani C; Occhiuto M; Pepe J
Intern Emerg Med; 2017 Oct; 12(7):915-921. PubMed ID: 28780668
[TBL] [Abstract][Full Text] [Related]
19. Effect of osteoporosis medications on fracture healing.
Hegde V; Jo JE; Andreopoulou P; Lane JM
Osteoporos Int; 2016 Mar; 27(3):861-871. PubMed ID: 26419471
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Bone-Forming Therapies for the Management of Osteoporosis.
Sølling ASK; Harsløf T; Langdahl B
Drugs Aging; 2019 Jul; 36(7):625-638. PubMed ID: 31066015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
